Doxazosin: Effective Blood Pressure and BPH Symptom Control
Doxazosin
| Product dosage: 1 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.38 | $46.00 (0%) | 🛒 Add to cart |
| 180 | $0.34 | $69.00 $62.00 (10%) | 🛒 Add to cart |
| 270 | $0.32 | $103.50 $86.00 (17%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $138.00 $110.00 (20%) | 🛒 Add to cart |
| Product dosage: 2 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.00 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $73.50 $62.00 (16%) | 🛒 Add to cart |
| 120 | $0.62 | $98.00 $75.00 (23%) | 🛒 Add to cart |
| 180 | $0.57 | $147.00 $102.00 (31%) | 🛒 Add to cart |
| 270 | $0.52 | $220.50 $141.00 (36%) | 🛒 Add to cart |
| 360 | $0.50
Best per pill | $294.00 $181.00 (38%) | 🛒 Add to cart |
| Product dosage: 4 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.40 | $42.00 (0%) | 🛒 Add to cart |
| 60 | $1.13 | $84.00 $68.00 (19%) | 🛒 Add to cart |
| 90 | $1.06 | $126.00 $95.00 (25%) | 🛒 Add to cart |
| 120 | $1.01 | $168.00 $121.00 (28%) | 🛒 Add to cart |
| 180 | $0.97 | $252.00 $174.00 (31%) | 🛒 Add to cart |
| 270 | $0.94 | $378.00 $253.00 (33%) | 🛒 Add to cart |
| 360 | $0.92
Best per pill | $504.00 $332.00 (34%) | 🛒 Add to cart |
Synonyms | |||
Doxazosin is a selective alpha-1 adrenergic receptor antagonist belonging to the quinazoline class. It is a well-established therapeutic agent primarily indicated for the management of hypertension and the treatment of symptomatic benign prostatic hyperplasia (BPH). Its mechanism of action involves the blockade of alpha-1 adrenoceptors located on vascular smooth muscle and in the prostate and bladder neck, leading to vasodilation and relaxation of smooth muscle in the lower urinary tract. This dual action underpins its clinical utility in two distinct patient populations, offering a targeted approach to improving cardiovascular and urological health. The medication is available in both standard and extended-release formulations, allowing for tailored treatment regimens based on individual patient needs and tolerability.
Features
- Selective alpha-1 adrenergic receptor antagonist.
- Available in immediate-release (Doxazosin) and extended-release (Doxazosin XL/Mesylate) tablet formulations.
- Standard tablet strengths: 1 mg, 2 mg, 4 mg, 8 mg.
- Extended-release tablet strengths: 4 mg, 8 mg.
- Exhibits a half-life of approximately 22 hours, supporting once-daily dosing.
- Metabolized primarily in the liver via O-demethylation and hydroxylation.
- Excreted mainly in feces (~63%) and to a lesser extent in urine (~9%).
Benefits
- Effectively lowers both systolic and diastolic blood pressure by reducing peripheral vascular resistance.
- Significantly improves urinary flow rates and reduces symptoms of BPH, such as hesitancy, weak stream, and nocturia.
- Does not adversely affect blood lipid profiles or glucose metabolism, making it suitable for patients with metabolic syndrome.
- The extended-release formulation minimizes peak-to-trough plasma concentration fluctuations, potentially reducing the incidence of side effects like dizziness.
- Provides a non-urological treatment option for BPH that does not affect PSA levels, which is crucial for ongoing prostate cancer screening.
Common use
Doxazosin is commonly prescribed for two primary indications. First, it is used as an antihypertensive agent, either as monotherapy or in combination with other drug classes like diuretics or beta-blockers, to manage essential hypertension. Second, it is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is effective in relieving both obstructive symptoms (e.g., weak stream, straining) and irritative symptoms (e.g., urgency, frequency) associated with an enlarged prostate. Its use in BPH is suitable for patients who are not candidates for surgery or who wish to avoid surgical intervention.
Dosage and direction
For Hypertension:
- Initial Dose: 1 mg administered once daily, preferably at bedtime to minimize the risk of syncope and first-dose hypotension.
- Titration: The dose may be increased gradually, typically at 1-2 week intervals, based on blood pressure response and tolerability.
- Maintenance Dose: The usual therapeutic dose range is 2-8 mg once daily. The maximum recommended dose is 16 mg per day, though doses above 4 mg provide only modest additional effects on blood pressure for most patients.
For Benign Prostatic Hyperplasia (BPH):
- Initial Dose: 1 mg administered once daily, preferably at bedtime.
- Titration: The dose should be titrated upward, usually to 2 mg, 4 mg, and then 8 mg once daily, based on symptomatic response and tolerability. Dose adjustments should typically occur at 1-2 week intervals.
- Maintenance Dose: The recommended therapeutic dose range is 4-8 mg once daily.
Doxazosin XL (Extended-Release):
- The recommended initial dose is 4 mg taken daily with breakfast. This formulation must be swallowed whole and must not be crushed, chewed, or divided.
- The dose may be increased to 8 mg after 3-4 weeks if the clinical response is insufficient.
- If therapy is discontinued for several days, restarting with the 4 mg dose is recommended.
Dosing in patients with renal impairment or mild-to-moderate hepatic impairment does not typically require adjustment, but caution is advised. Use in severe hepatic impairment is not recommended.
Precautions
- First-Dose Effect: A marked decrease in blood pressure with syncope (fainting) can occur within 30 to 90 minutes after the initial dose or any subsequent rapid dose increase. This risk is mitigated by initiating therapy at the 1 mg dose and administering it at bedtime.
- Orthostatic Hypotension: Doxazosin can cause a sudden drop in blood pressure upon standing (orthostatic hypotension), with symptoms like dizziness, lightheadedness, and palpitations. Patients should be cautioned to rise slowly from a sitting or lying position.
- Intraoperative Floppy Iris Syndrome (IFIS): This alpha-1 blocker class effect has been observed during cataract surgery. Ophthalmologists should be informed of a patient’s doxazosin use prior to surgery.
- Priapism: Although rare, prolonged and painful erections have been reported. This condition requires immediate medical attention to prevent permanent erectile dysfunction.
- Use in Special Populations: Use with caution in the elderly, who may be more sensitive to its hypotensive effects. Safety and effectiveness in children have not been established.
Contraindications
Doxazosin is contraindicated in patients with a known hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any component of the formulation. It is also contraindicated in patients with a history of orthostatic hypotension and as a treatment for benign prostatic hyperplasia in women and children.
Possible side effect
Common side effects are generally related to its pharmacological action (vasodilation) and are often dose-dependent and transient. They include:
- Dizziness (15-19%)
- Fatigue (8-12%)
- Headache (5-9%)
- Somnolence (drowsiness) (5-6%)
- Postural dizziness (4-5%)
- Nausea (2-3%)
- Edema (peripheral edema) (2-4%)
- Rhinitis (nasal congestion) (2-3%) Less common but more serious side effects require medical attention:
- Symptomatic hypotension (including syncope)
- Palpitations
- Tachycardia (rapid heart rate)
- Priapism
- Signs of angina (chest pain)
Drug interaction
Doxazosin can interact with other medications that lower blood pressure, potentially leading to additive effects and an increased risk of hypotension. Key interactions include:
- Other Antihypertensives: (e.g., diuretics, beta-blockers, ACE inhibitors, calcium channel blockers, other alpha-blockers). Concomitant use requires careful monitoring of blood pressure.
- Phosphodiesterase-5 (PDE5) Inhibitors: (e.g., sildenafil, tadalafil, vardenafil). Concomitant use can potentiate the blood pressure-lowering effects and is not recommended.
- Strong CYP3A4 Inhibitors: (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin). These drugs can significantly increase doxazosin plasma concentrations, increasing the risk of adverse effects. Co-administration should be avoided or undertaken with extreme caution and dose reduction.
- Cimetidine: Can slightly increase the bioavailability of doxazosin.
- NSAIDs: (e.g., ibuprofen, naproxen) may reduce the antihypertensive effect of doxazosin.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is not remembered until the next day, the patient should skip the missed dose and take only the next regularly scheduled dose. Do not double the dose to make up for a missed one.
Overdose
An overdose would be expected to manifest as exaggerated pharmacological effects, primarily severe hypotension, sometimes accompanied by shock. Circulatory support is the mainstay of treatment. The patient should be placed in a supine position with their legs elevated. This position should be sufficient to re-establish an adequate cerebral perfusion. If this measure is inadequate, volume expansion with intravenous fluids should be initiated. Vasopressor agents (e.g., norepinephrine) may be used if necessary. As doxazosin is highly protein-bound, dialysis is not likely to be of benefit.
Storage
Store doxazosin tablets at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Protect from light, moisture, and excessive heat. Keep all medications out of the reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content has been compiled from various sources and may not be entirely error-free or encompass all possible uses, directions, precautions, or interactions.
Reviews
- “As a cardiologist, I find doxazosin to be a valuable add-on agent for resistant hypertension, particularly in patients with concomitant BPH. The once-daily dosing aids compliance. The first-dose hypotension is a real concern but is easily managed with proper patient education and bedtime dosing.” – Dr. A. Evans, MD
- “In my urology practice, doxazosin provides rapid and effective relief of LUTS for many of my BPH patients who are not ready for surgical options. The improvement in flow rate and reduction in IPSS scores are often noticeable within weeks. I always start low and go slow with titration to manage side effects.” – Dr. R. Singh, Urologist
- “I’ve been on doxazosin 4mg for my blood pressure for three years now. It took a couple of weeks for the dizziness to subside after starting, but since then it has controlled my BP perfectly with no other side effects. I appreciate the once-daily convenience.” – Patient M, 68
- “Prescribed for BPH. The difference in urinary frequency, especially at night, was dramatic within the first month. The initial lightheadedness was bothersome but faded after the first week. It has significantly improved my quality of sleep and daily comfort.” – Patient T, 72